Stem cells are like "seeds of life", which can differentiate into multifunctional cells under certain conditions and have the ability to repair various tissue functions and regenerate organs, so they are called "universal cells" by the medical community, and the continuous progress and development of stem cell technology has also played a huge role in human disease research and life extension.
Some experts said that in recent years, traditional medical methods such as chemical drugs and surgery have been increasingly challenged by the aging population, chronic diseases and high incidence of tumors. The new cell therapy technologies, such as stem cells and immune cell therapy, have developed rapidly and have become the focus of research and development in the biomedical field in the world.
In the research and development of chemical drugs, China lags far behind the developed countries in Europe and America. Stem cells are one of the few fields in China that are in a "parallel running" position in the world, and they are a brand-new field to catch up with the international and benchmark China's position; It is also a livelihood event that leads the medical trend and benefits the people.
China's quantum communication, neutrinos, iron-based superconductivity, felfermions, stem cells and regenerative medicine have reached the forefront of the world's important scientific and technological achievements.
"We are now one of the main forces of the first camp in the field of scientific and technological research and transformation and application. This kind of opportunity may not be available in many fields, and we are comparable to the international advanced level. "
As one of the most advanced and popular directions in the field of medical research, stem cell technology is bringing dawn to the treatment of more intractable and difficult diseases, and the clinical research of stem cells in China is in full swing.
Up to now, China's medical research registration and filing information system and the Health and Health Commission have published more than 1 stem cell clinical research filing projects, and 133 stem cell clinical research filing institutions have been approved (including military hospitals). By May 222, 38 applications for clinical trials of stem cell drugs were accepted in China, of which 28 were allowed to enter clinical trials (IND) by tacit approval.
At present, the therapeutic effects of 28 new stem cell drugs approved for IND are mainly reflected in two aspects: tissue repair and immunomodulation, according to the human system to which each indication belongs.